111049 ⎘
ssRNA viruses negative-sense; Details; Paramyxoviridae; Sendai virus; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Composition and Use Method Therefor
#2PRODUCTION METHOD FOR INDUCED PLURIPOTENT STEM CELLS
#3RNA VIRUS-DERIVED CHIMERIC ENVELOPE PROTEIN AND RNA VIRUS VECTOR HAVING SAME
#4TEMPERATURE-SENSITIVE NEGATIVE-STRAND RNA VIRUS OR VIRUS VECTOR AND RNA GENOME THEREOF
#5RETROVIRAL VECTORS
#6PRODUCTION METHOD FOR INDUCED PLURIPOTENT STEM CELLS
#7METHOD OF MANUFACTURING AUTOLOGOUS CARDIAC LINEAGE CELLS
#8Compositions And Methods For Differentiation Of Human Pluripotent Stem Cells Into Desired Cell Types
#9METHOD FOR PRODUCING PLURIPOTENT STEM CELLS
#10Reprogramming Somatic Cells on Microcarriers
#11METHOD OF PRODUCING NEGATIVE-STRAND RNA VIRUS VECTOR AND PRODUCED NEGATIVE-STRAND RNA VIRUS VECTOR
#12RETROVIRAL VECTORS
#13Method for Producing Naive Human IPS Cells From Somatic Cells
#14METHOD FOR PRODUCING REVERSIBLY IMMORTALIZED CELL
#15Quality Improving Agent for IPS Cells, Method of Producing IPS Cells, IPS Cells, and Composition for Producing IPS Cells
#16METHOD FOR PRODUCING STEM CELLS AND METHOD FOR PRODUCING SOMATIC CELLS
#17TEMPERATURE-BASED TRANSIENT DELIVERY OF ZSCAN4 NUCLEIC ACIDS AND PROTEINS TO CELLS AND TISSUES
#18PLATFORM FOR THE INDUCTION & MAINTENANCE OF GROUND STATE PLURIPOTENCY
#19METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELLS BY REPROGRAMMING SOMATIC CELLS
#20RETROVIRAL VECTORS
#21ARTIFICIAL MICRORNA PRECURSOR AND IMPROVED MICRORNA EXPRESSION VECTOR CONTAINING THE SAME
#22Compositions and methods for differentiation of human pluripotent stem cells into desired cell types
#23VIRAL DELIVERY OF RNA UTILIZING SELF-CLEAVING RIBOZYMES AND CRISPR-BASED APPLICATIONS THEREOF
#24Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA
#25Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA
#26Infectious disease vaccine using non-infectious paramyxovirus particle
#27Viral delivery of RNA utilizing self-cleaving ribozymes and CRISPR-based applications thereof
#28Uses of induced neural stem cells derived from peripheral blood mononuclear cells
#29Platform for the induction and maintenance of ground state pluripotency
#30Optimized HIV envelope gene and expression thereof
#31Compositions and methods for differentiation of human pluripotent stem cells into desired cell types
#32IMPROVED NEGATIVE-STRAND RNA VIRAL VECTOR
#33Method for correcting a genetic sequence
#34Anti-vaccine using sendai virus as vector
#35Modified Sendai virus vaccine and imaging vector
#36Optimized HIV envelope gene and expression thereof
#37GENE THERAPY FOR DIABETIC ISCHEMIC DISEASE
#38Method for improving efficiency of inducing pluripotent stem cell
#39Method for production of reprogrammed cell using chromosomally unintegrated virus vector
#40Method for production of reprogrammed cell using chromosomally unintegrated virus vector
#41METHOD FOR EXPRESSION OF HETEROLOGOUS PROTEINS USING A RECOMBINANT NEGATIVE-STRAND RNA VIRUS VECTOR
#42Compositions and methods for transient expression of recombinant RNA
#43Modified Sendai virus vaccine and imaging vector
#44Composition for inducing pluripotent stem cell, and use thereof
#45Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same
#46METHOD FOR ENHANCING EXPRESSION OF RECOMBINANT PROTEIN
#47VECTOR FOR TREATING ALZHEIMER'S DISEASE
#48Method for production of reprogrammed cell using chromosomally unintegrated virus vector
#49Paramyxovirus vector encoding angiogenesis gene and use thereof
#50METHODS FOR PRODUCING ANTIBODIES
#51GENE THERAPY FOR DIABETIC ISCHEMIC DISEASE
#52Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same
#53VECTORS WITH MODIFIED PROTEASE-DEPENDENT TROPISM
#54AIDS virus vaccines using Sendai virus vector
#55NON-REPLICATING PARAMYXOVIRIDAE VIRUS VECTOR
#56VIRAL VECTOR FOR GENE THERAPY
#57Persistently infective vector
#58NOVEL PROTEIN EXPRESSION SYSTEM
#59PARAMYXOVIRUS VECTOR ENCODING ANGIOGENESIS GENE AND USE THEREOF
#60Mutant paramyxovirus and method for production thereof
#61Therapeutic Agent For Alzheimer's Disease
#62Compositions and Methods for the Treatment of Inflammatory Bowel Disease Utilizing NF-KappaB Decoy Polynucleotides
#63Highly safe intranasally administrable gene vaccines for treating alzheimer's disease
#64Vectors with modified protease-dependent tropism
#65Gene therapy for diabetic ischemic disease
#66Method for detecting cancer and a method for suppressing cancer
#67Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair
#68Method for Producing Gene Transferred Denritic Cells
#69Gene therapy for tumors using minus-strand RNA viral vectors encoding immunostimulatory cytokines
#70Paramyxovirus-derived RNP
#71Compositions and methods for the treatment of inflammatory bowel disease utilizing NF-kappaB decoy polynucleotides
#72Paramyxovirus vector encoding ribozyme and utilization thereof
#73Methods of Tranducing genes into T cells
#74Method for introducing a biological molecule using a viral envelope and heparin and system therefore
#75Negative-sense RNA virus vector for nerve cell
#76Recombinant sendai virus
#77Vectors with modified protease-dependent tropism
#78Pramyxovirusl vectors encoding antibody and utilization thereof
#79Negative-sense RNA virus vector for nerve cell
#80Methods of examining (-) strand rna virus vectors having lowered ability to form grains and method of constructing the same
#81Method for producing induced pluripotent stem cells